Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production

Pathology and Oncology Research

Volumn 18, Issue 4, 2012, Pages 793-802

  Calabuig Fariñas, Silvia ^a   Benso, Rosario Gil ^a   Szuhai, Karoly ^b   Machado, Isidro ^a   López Guerrero, José Antonio ^c   De Jong, Danielle ^b   Peydró, Amando ^a   Miguel, Teresa San ^a   Navarro, Lara ^a   Pellín, Antonio ^a   LLombart Bosch, Antonio ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

Bone tumor; Cell line; Chondrosarcoma; Grade II; Karyotype; Matrix

Indexed keywords

CELECOXIB; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; TEMOZOLOMIDE;

9P21 GENE; ADJUVANT CHEMOTHERAPY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOGENESIS; CASE REPORT; CELL DEDIFFERENTIATION; CELL LINE; CH 3573 CELL; CHONDROSARCOMA; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; GENETIC STABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MALE; MOLECULAR GENETICS; MOUSE; NONHUMAN; SURVIVAL RATE; TP53 GENE; TUMOR GENE; TUMOR VOLUME; TUMOR XENOGRAFT;

ADULT; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CHONDROSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MICE, NUDE; NEOPLASM GRADING; NEOPLASM PROTEINS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84868457824     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-012-9505-0     Document Type: Article

References (35)

1. Evans HL, Ayala AG, Romsdahl MM (1977) Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer 40(2):818-31
2. Rozeman LB, Cleton-Jansen AM, Hogendoorn PC (2006) Pathology of primary malignant bone and cartilage tumour. Int Orthop 30 (6):437-44
3. Puri A, Shah M, Agarwal MG, Jambhekar NA, Basappa P (2009) Chondrosarcoma of bone: does the size of the tumor, the presence of a pathologic fracture, or prior intervention have an impact on local control and survival? J Cancer Res Ther 5(1):14-9
4. Riedel RF, Larrier N, Dodd L, Kirsch D, Martinez S, Brigman BE (2009) The clinical management of chondrosarcoma. Curr Treat Options Oncol 10(1-2):94-106
5. Takigawa M, Tajima K, Pan HO et al (1989) Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res 49(14):3996-4002
6. Takigawa M, Pan HO, Kinoshita A, Tajima K, Takano Y (1991) Establishment from a human chondrosarcoma of a new immortal cell line with high tumorigenicity in vivo, which is able to form proteoglycan-rich cartilage-like nodules and to respond to insulin in vitro. Int J Cancer 48(5):717-25
7. Ikemoto S, Sugimura K, Yoshida N, Nakatani T (2004) Chondrosarcoma of the urinary bladder and establishment of a human chondrosarcoma cell line (OCUU-6). Hum Cell 17(3):93-6
8. Kudo N, Ogose A, Hotta T et al (2007) Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation. Virchows Arch 451(3):691-9
9. Yang L, Chen Q, Zhang S, Wang X, Li W, Wen J et al (2009) A novel mutated cell line with characteristics of dedifferentiated chondrosarcoma. Int J Mol Med 24(4):427-35
10. Gil-Benso R, Lopez-Gines C, Lopez-Guerrero JA et al (2003) Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: comparative histologic and genetic studies with its tumor of origin. Lab Invest 83(6):877-87
11. Kalinski T, Krueger S, Pelz AF et al (2005) Establishment and characterization of the permanent human cell line C3842 derived from a secondary chondrosarcoma in Ollier's disease. Virchows Arch 446(3):287-99
12. Oshiro Y, Chaturvedi V, Hayden D et al (1998) Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study. Cancer 83(11):2324-34
13. Terek RM, Healey JH, Garin-Chesa P, Mak S, Huvos A, Albino AP (1998) p53 mutations in chondrosarcoma. Diagn Mol Pathol 7 (1):51-6
14. Scully SP, Layfield LJ, Harrelson JM (1997) Prognostic markers in chondrosarcoma: evaluation of cell proliferation and of regulators of the cell cycle. Sarcoma; 1(2):79-87
15. Szuhai K, Tanke HJ (2006) COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping. Nat Protoc 1(1):264-75
16. Lopez-Guerrero JA, Lopez-Gines C, Pellin A, Carda C, Llombart-Bosch A (2004) Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma. Diagn Mol Pathol 13(2):81-91
17. Lopez-Guerrero JA, Pellin A, Noguera R, Carda C, Llombart-Bosch A (2001) Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest 81(6):803-14
18. Okamoto S, Hisaoka M, Ishida T et al (2001) Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Hum Pathol 32(10):1116-24
19. Tallini G, Dorfman H, Brys P et al (2002) Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. J Pathol 196(2):194-203
20. Mandahl N, Gustafson P, Mertens F et al (2002) Cytogenetic aberrations and their prognostic impact in chondrosarcoma Genes Chromosomes. Cancer 33(2):188-200
21. Bovee JV, Sciot R, Dal Cin P et al (2001) Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol 10(4):228-35
22. Hallor KH, Staaf J, Bovee JV et al (2009) Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors. Clin Cancer Res 15(8):2685-94
23. Rozeman LB, Szuhai K, Schrage YM et al (2006) Arraycomparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations. Cancer 107 (2):380-8
24. Larramendy ML, Tarkkanen M, Valle J et al (1997) Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas. Am J Pathol 150 (2):685-91
25. Yamaguchi T, Toguchida J, Wadayama B et al (1996) Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Anticancer Res 16(4A):2009-15
26. Eisenberg MB, Woloschak M, Sen C, Wolfe D (1997) Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas. Surg Neurol 47 (2):156-60, discussion 60-1
27. Gunawan B, Weber M, Bergmann F, Wildberger J, Niethard FU, Fuzesi L (2000) Clonal chromosome abnormalities in enchondromas and chondrosarcomas. Cancer Genet Cytogenet 120(2):127-30
28. Asp J, Inerot S, Block JA, Lindahl A (2001) Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma. J Orthop Res 19(1):149-54
29. Jagasia AA, Block JA, Qureshi A et al (1996) Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas. Cancer Lett 105(1):91-103
30. Jagasia AA, Block JA, Diaz MO et al (1996) Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma. Cancer Lett 105(1):77-90
31. Asp J, Brantsing C, Benassi MS et al (2001) Changes in p14(ARF) do not play a primary role in human chondrosarcoma tissues. Int J Cancer 93(5):703-5
32. Schrage YM, Lam S, Jochemsen AG et al (2009) Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro. J Cell Mol Med 13(9A):2843-52
33. Moussavi-Harami F, Mollano A, Martin JA et al (2006) Intrinsic radiation resistance in human chondrosarcoma cells. Biochem Biophys Res Commun 346(2):379-85
34. Rozeman LB, Hogendoorn PC, Bovee JV (2002) Diagnosis and prognosis of chondrosarcoma of bone. Expert Rev Mol Diagn 2 (5):461-72
35. Bovee JV, van Royen M, Bardoel AF et al (2000) Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol 157(5):1587-95